{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:46:42Z","timestamp":1790192802800,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":1467,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.kint.2019.05.014","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T22:35:21Z","timestamp":1559255721000},"page":"995-1004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome"],"prefix":"10.1016","volume":"96","author":[{"given":"Teresa","family":"Cavero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Arjona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Caravaca-Font\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rabasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"de la Cerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Jarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Alc\u00e1zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Fulladosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Carbayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Anaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cobelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Baltar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Mart\u00ednez-Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mac\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Draibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Pallard\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xoana","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Rodr\u00edguez de C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Praga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2019.05.014_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2019.05.014_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2019.05.014_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u00abKidney Disease: Improving Global Outcomes\u00bb (KDIGO) controversies conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.05.014_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/MOH.0b013e32833cae86","article-title":"Atypical hemolytic uremic syndrome","volume":"17","author":"Kavanagh","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.kint.2019.05.014_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nefro.2015.07.005","article-title":"An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document","volume":"35","author":"Campistol","year":"2015","journal-title":"Nefrologia"},{"key":"10.1016\/j.kint.2019.05.014_bib6","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.05.014_bib7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies","volume":"87","author":"Licht","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.05.014_bib8","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.05.014_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","article-title":"Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial","volume":"68","author":"Fakhouri","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.05.014_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ekir.2016.06.005","article-title":"Complement-mediated glomerular diseases: a tale of 3 pathways","volume":"1","author":"Bomback","year":"2016","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2019.05.014_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2006-939767","article-title":"Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome","volume":"32","author":"Zimmerhackl","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.kint.2019.05.014_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0272-6386(12)80449-5","article-title":"Inherited hemolytic uremic syndrome in adults","volume":"19","author":"Berns","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.05.014_bib13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2019.05.014_bib14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ndt\/gfw453","article-title":"Eculizumab in secondary atypical haemolytic uraemic syndrome","volume":"32","author":"Cavero","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.05.014_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1291\/hypres.28.89","article-title":"Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)\/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?","volume":"28","author":"Shibagaki","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.kint.2019.05.014_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.HYP.0000151620.17905.ee","article-title":"Microangiopathic hemolysis and renal failure in malignant hypertension","volume":"45","author":"van den Born","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2019.05.014_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jash.2015.12.007","article-title":"The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy","volume":"10","author":"Mathew","year":"2016","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.kint.2019.05.014_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","article-title":"Aldosterone induces acute endothelial dysfunction in\u00a0vivo in humans: evidence for an aldosterone-induced vasculopathy","volume":"103","author":"Farquharson","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.kint.2019.05.014_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jsbmb.2008.03.005","article-title":"Aldosterone and the vascular system","volume":"109","author":"Cachofeiro","year":"2008","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.kint.2019.05.014_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1291\/hypres.31.479","article-title":"Renal thrombotic microangiopathies induced by severe hypertension","volume":"31","author":"Zhang","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.kint.2019.05.014_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/jch.12664","article-title":"Does anticomplement therapy have a role in the management of malignant hypertension?","volume":"18","author":"Tsai","year":"2016","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.kint.2019.05.014_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/0009922811412942","article-title":"Atypical hemolytic-uremic syndrome in a child presenting with malignant hypertension","volume":"52","author":"Totina","year":"2013","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.kint.2019.05.014_bib23","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.kint.2016.12.009","article-title":"Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities","volume":"91","author":"Timmermans","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.05.014_bib24","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1681\/ASN.2018020184","article-title":"C5b9 formation on endothelial cells reflects complement defects among patients with renal thrombotic microangiopathy and severe hypertension","volume":"29","author":"Timmermans","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.05.014_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/modpathol.2017.154","article-title":"Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy","volume":"31","author":"Larsen","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.kint.2019.05.014_bib26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ckj\/sfu116","article-title":"Malignant hypertension with thrombotic microangiopathy and persistent acute kidney injury (AKI)","volume":"7","author":"Nzerue","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2019.05.014_bib27","doi-asserted-by":"crossref","first-page":"680502","DOI":"10.1155\/2014\/680502","article-title":"Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China","volume":"2014","author":"Yu","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.kint.2019.05.014_bib28","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/HYPERTENSIONAHA.107.103127","article-title":"Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension","volume":"51","author":"van den Born","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2019.05.014_bib29","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/HJH.0b013e328345023d","article-title":"Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis","volume":"29","author":"van den Born","year":"2001","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.kint.2019.05.014_bib30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.kint.2017.03.041","article-title":"Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy","volume":"92","author":"Tortajada","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.05.014_bib31","first-page":"42","article-title":"Malignant hypertension: a type of IgA nephropathy manifestation with poor prognosis","volume":"35","author":"Sevillano","year":"2015","journal-title":"Nefrologia"},{"key":"10.1016\/j.kint.2019.05.014_bib32","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2019.05.014_bib33","first-page":"140","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.kint.2019.05.014_bib34","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1097\/01.hjh.0000249710.21146.38","article-title":"Ethnic disparities in the incidence, presentation and complications of malignant hypertension","volume":"24","author":"van den Born","year":"2006","journal-title":"J\u00a0Hypertens"},{"issue":"suppl 2","key":"10.1016\/j.kint.2019.05.014_bib35","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","author":"Eknoyan","year":"2012","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819305824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819305824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:53:33Z","timestamp":1758761613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253819305824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0085253819305824"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2019.05.014","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2019.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}